Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Aug 1;7(8):e2428372.
doi: 10.1001/jamanetworkopen.2024.28372.

Efficacy of a Mobile App-Based Intervention for Young Adults With Anxiety Disorders: A Randomized Clinical Trial

Affiliations
Randomized Controlled Trial

Efficacy of a Mobile App-Based Intervention for Young Adults With Anxiety Disorders: A Randomized Clinical Trial

Jennifer N Bress et al. JAMA Netw Open. .

Abstract

Importance: Anxiety disorders are prevalent and undertreated among young adults. Digital mental health interventions for anxiety are promising but limited by a narrow range of therapeutic components and low user engagement.

Objective: To investigate the efficacy of and engagement with Maya, a scalable, self-guided, comprehensive mobile cognitive behavioral therapy (CBT) intervention with embedded engagement features, comparing the effects of 3 incentive conditions.

Design, setting, and participants: This randomized clinical trial recruited young adults aged 18 to 25 years with anxiety disorders through online advertisements and outpatient psychiatry clinics at Weill Cornell Medicine. Enrollment was between June 16, 2021, and November 11, 2022. Data analysis was performed from December 21, 2022, to June 14, 2024.

Intervention: Participants received a 6-week program of the intervention and were randomized to 1 of 3 different text message-based incentive conditions (gain-framed, loss-framed, or gain-social support).

Main outcomes and measures: The primary outcome was change in anxious symptoms from baseline to end of treatment, as measured by the Hamilton Anxiety Rating Scale (HAM-A). The Anxiety Sensitivity Index and the Leibowitz Social Anxiety Scale scores were secondary measures.

Results: The sample consisted of 59 participants (mean [SD] age, 23.1 [1.9] years; 46 [78%] female; 22 [37%] Asian, 3 [5%] Black, 5 [8%] Hispanic or Latino, 1 [2%] American Indian or Alaska Native, 25 [42%] White, and 6 [10%] >1 race; 32 [54%] college-educated and 12 [20%] graduate or professional school-educated; mean [SD] baseline HAM-A score, 15.0 [6.5]). Anxiety, measured by HAM-A, decreased across conditions from baseline to end of the intervention (mean difference, -5.64; 95% CI, -7.23 to -4.05), and symptomatic improvement was maintained at the week 12 follow-up (baseline to follow-up mean difference, -5.67; 95% CI, -7.29 to -4.04). However, there was no evidence that change in anxiety differed by incentive condition (loss-framed vs gain-social support mean difference, -1.40; 95% CI, -4.72 to 1.93; gain-framed vs gain-social support mean difference, 1.38; 95% CI, -1.19 to 3.96). Secondary anxiety measures (Anxiety Sensitivity Index and Liebowitz Social Anxiety Scale scores) showed a similar pattern of improvement, with no evidence of differences between incentive conditions. Participants completed most of the 12 sessions (mean [SD], 10.8 [2.1]; 95% CI, 10.3-11.4), and User Mobile Application Rating Scale app quality ratings exceeded the published threshold for acceptability at all study visits. There was no evidence that either session completion or app quality ratings differed by incentive condition.

Conclusions and relevance: In this randomized clinical trial of an app-based intervention for anxiety, the primary hypothesis that improvement in anxiety would be greatest in the condition using gain of points plus social incentives was not supported; however, the results suggest that a CBT application incorporating a full suite of CBT skills and embedded user engagement features was efficacious in improving symptoms in young adults with anxiety disorders. Given these findings, digital interventions represent a promising step toward wider dissemination of high-quality, evidence-based interventions.

Trial registration: ClinicalTrials.gov Identifier: NCT05130281.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Bress reported receiving grants from the National Institute of Mental Health, research funding from the Joseph Sanchez Foundation, and personal fees from Inside Edge Consulting Group outside the submitted work. Dr Jaywant reported receiving grants from the National Institute of Mental Health and personal fees from Axem Neurotechnology Inc outside the submitted work. Dr Bennett reported serving on the speakers’ bureau for Lyra Inc and receiving royalties from UpToDate outside the submitted work. Dr Scult reported receiving personal fees from Modern Health, Akili Interactive, Big Health, Scenario, and Stressbuoy outside the submitted work. Dr Volpp reported being a part owner in VAL Health and serving as a scientific advisory board member with stock options with Thrive Global outside the submitted work. Dr Asch reported reported being a partner and part owner of VAL Health and receiving personal fees from Thrive Global outside the submitted work. Mr Balachandran reported receiving personal fees from Connect46 LLC outside the submitted work. Dr Perlis reported receiving personal fees from Burrage Capital Biotechnology, Vault Health Scientific, Genomind Scientific, Psy Therapeutics, Circular Genomics, Belle Artificial Intelligence, Swan AI Studios, Mila Health, and Alkermes outside the submitted work. Dr Gunning reported receiving grants from the National Institutes of Health and Akili Interactive, and personal fees from the American Medical Association outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. CONSORT Diagram Illustrating Number of Participants Included at Each Point in the Study From Enrollment to Analysis
Figure 2.
Figure 2.. Results of the Linear Mixed-Effects Model Demonstrating Change in Outcome Measure by Time and Incentive Condition
Error bars represent SEs. ASI indicates Anxiety Sensitivity Index; HAM-A, Hamilton Anxiety Rating Scale; HAM-D, Hamilton Depression Rating Scale; and LSAS, Liebowitz Social Anxiety Scale.

References

    1. Duffy ME, Twenge JM, Joiner TE. Trends in mood and anxiety symptoms and suicide-related outcomes among U.S. undergraduates, 2007-2018: evidence from two national surveys. J Adolesc Health. 2019;65(5):590-598. doi: 10.1016/j.jadohealth.2019.04.033 - DOI - PubMed
    1. Goodwin RD, Weinberger AH, Kim JH, Wu M, Galea S. Trends in anxiety among adults in the United States, 2008-2018: rapid increases among young adults. J Psychiatr Res. 2020;130:441-446. doi: 10.1016/j.jpsychires.2020.08.014 - DOI - PMC - PubMed
    1. Office of the Surgeon General . Protecting Youth Mental Health: The U.S. Surgeon General’s Advisory. US Dept of Health and Human Services; 2021. - PubMed
    1. Bruffaerts R, Mortier P, Kiekens G, et al. Mental health problems in college freshmen: prevalence and academic functioning. J Affect Disord. 2018;225:97-103. doi: 10.1016/j.jad.2017.07.044 - DOI - PMC - PubMed
    1. Essau CA, Lewinsohn PM, Olaya B, Seeley JR. Anxiety disorders in adolescents and psychosocial outcomes at age 30. J Affect Disord. 2014;163:125-132. doi: 10.1016/j.jad.2013.12.033 - DOI - PMC - PubMed

Publication types

Associated data